Glycodelin: A novel serum anti-inflammatory marker in type 1 diabetic retinopathy during pregnancy

Acta Ophthalmologica Scandinavica

Volumn 85, Issue 1, 2007, Pages 46-49

  Loukovaara, Sirpa ^a   Immonen, Ilkka R J ^a   Loukovaara, Mikko J ^a   Koistinen, Riitta ^a   Kaaja, Risto J ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Diabetic retinopathy; Glycodelin; Placental protein 14; Pregnancy; Type1 diabetes mellitus

Indexed keywords

PLACENTA PROTEIN 14;

ADULT; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC RETINOPATHY; DISEASE COURSE; DISEASE MARKER; EYE PHOTOGRAPHY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; IMMUNOFLUORESCENCE TEST; IMMUNOMODULATION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; OPHTHALMOSCOPY; PATHOGENESIS; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN FUNCTION; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY;

ADULT; BIOLOGICAL MARKERS; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; FEMALE; FLUOROIMMUNOASSAY; GESTATIONAL AGE; GLYCOPROTEINS; HEMOGLOBINS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PREGNANCY; PREGNANCY IN DIABETICS; PREGNANCY PROTEINS; PROSPECTIVE STUDIES;

EID: 33846416526     PISSN: 13953907     EISSN: 16000420     Source Type: Journal    
DOI: 10.1111/j.1600-0420.2006.00766.x     Document Type: Article

References (24)

1. Adamis AP (2002): Is diabetic retinopathy an inflammatory disease? Br J Ophthalmol 86: 363-365.
2. Diabetes Control and Complications Trial (DCCT) Research Group (1993): The effect of intensive treatment of diabetes on the development and progression of longterm complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986.
3. Early Treatment Diabetic Retinopathy Study Research Group (1991): Grading diabetic retinopathy from stereoscopic colour fundus photographs -an extension of the modified Airlie House classification. EDTRS Report 10. Ophthalmology 98: 786-806.
4. Frank RN (2004): Diabetic retinopathy. N Engl J Med 350: 48-58.
5. Hellstedt T, Kaaja R, Teramo K & Immonen I (1997): The effect of pregnancy on mild diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 235: 437-441.
6. Jeschke U, Wang X, Briese V, Friese K & Stahn R (2003): Glycodelin and amniotic fluid transferrin as inhibitors of E-selectin-mediated cell adhesion. Histochem Cell Biol 119: 345-354.
7. Joussen AM, Poulaki V, Mitsiades N, Kirchhof B, Koizumi K, Dohmen S & Adamis AP (2002): Non-steroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression. FASEB J 16: 438-440.
8. Julkunen M, Rutanen EM, Koskimies A, Ranta T, Bohn H & SeppäläM (1985): Distribution of placental protein 14 in tissues and body fluids during pregnancy. Br J Obstet Gynaecol 92: 1145-1151.
9. Kern TS & Engerman RL (2001): Pharmacological inhibition of diabetic retinopathy: Aminoguanidine and aspirin. Diabetes 50: 1636-1642.
10. Koistinen H, Koistinen R, Dell A et.al. (1996): Glycodelin from seminal plasma is a differentially glycosylated form of contraceptive glycodelin-A. Mol Hum Reprod 2: 759-765.
11. LogdbergAL & Wester L (2000): Immunocalins: a lipocalin subfamily that modulates immune and inflammatory responses. Biochim Biophys Acta 1482: 284-297.
12. Loukovaara S, Harju M, Kaaja R & Immonen I (2003): Retinal capillary blood flow in diabetic and non-diabetic women during pregnancy and postpartum period. Invest Ophthalmol Vis Sci 44: 1486-1491.
13. Loukovaara S, Immonen I, Koistinen R, Hiilesmaa V & Kaaja R (2005): Inflammatory markers and retinopathy in pregnancies complicated with type 1 diabetes. Eye 19: 422-430.
14. Loukovaara S, Immonen I, Koistinen R, Rudge J, Teramo K, Laatikainen L, Hiilesmaa V & Kaaja R (2004b): Angiopoietic factors and retinopathy in pregnancies complicated with type 1 diabetes. Diabetic Med 21: 697-704.
15. Loukovaara M, Leinonen P, Teramo K & Koistinen R (2004a): Cord serum glycodelin concentrations in normal pregnancies and pregnancies complicated by diabetes. Arch Gynecol Obstet 270: 161-164.
16. Martidis A, Duker JS, Greenberg PB, Rogers AH, Pulifiato CA, Reichel E & Baumal C (2002): Intravitreal triamcinolone for refractory diabetic macular oedema. Ophthalmology 109: 920-927.
17. Meleth AD, Agron E, Chan C-C et.al. (2005): Serum inflammatory markers in diabetic retinopathy. Invest Ophthalmol Vis Sci 46: 4295-4301.
18. Miyamoto K, Ogura Y, Kenmochi S & Honda Y (1997): Role of leucocytes in diabetic microcirculatory disturbances. Microvasc Res 54: 43-48.
19. Pockley AG & Bolton AE (1989): Placental protein 14 (PP14) inhibits the synthesis of interleukin-2 and the release of soluble interleukin-2 receptors from phytohaemagglutinin-stimulated lymphocytes. Clin Exp Immunol 77: 252-256.
20. Pockley AG & Bolton AE (1990): The effect of human placental protein 14 (PP14) on the production of interleukin-1 from mitogenically stimulated mononuclear cell cultures. Immunology 69: 277-281.
21. Schröder S, Palinski W & Schmid-Schönbein GW (1991): Activated monocytes and granulocytes, capillary non-perfusion and neovascularization in diabetic retinopathy. Am J Pathol 139: 81-100.
22. SeppäläM, Taylor RN, Koistinen H, Koistinen R & Milgrom E (2002)A Glycodelin: a major lipocalin protein of the reproductive axis with diverse actions in cell recognition and differentiation. Endocr Rev 23: 401-430.
23. Skyrme-Jones R & Meredith IT (2001): Soluble adhesion molecules, endothelial function and vitamin E in type 1 diabetes. Coron Artery Dis 12: 69-75.
24. Soubrane G, Canivet J & Coscas G (1985): Influence of pregnancy on the evolution of background retinopathy: Preliminary results of a prospective fluorescein angiography study. Int Ophthalmol Clin 8: 249-255.